Cargando…

SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management.

Background: Overweight and obesity are major health burdens in veterans, occurring at higher rates than the general population (78% vs 69%) and associate with chronic disease development. Self-efficacy is a person's ability to overcome the difficulties inherent in performing a specific task in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parziale, Andrew, Vallejo-Garcia, Franco, McCloskey, Karen, Callanan, Mae, Tenner, Craig, Alemán, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551665/ http://dx.doi.org/10.1210/js.2019-SAT-102

Ejemplares similares

MON-601 Obesity Pharmacotherapy Is Effective in the United States Veterans Affairs Patient Population: A Local and Virtual Cohort Study
por: Pendse, Jay, et al.
Publicado: (2020)

SAT-093 Effect of HIV Infection and Antiretroviral Therapy Use on Body Weight and Body Weight Changes over a 5-Year Period in US Veterans
por: Garcia, Jose, et al.
Publicado: (2019)

SAT-113 Cortisol and Weight Regain after Bariatric Surgery
por: Dias, Jenny, et al.
Publicado: (2019)

MON-LB102 Metformin-Induced Weight Loss in Patients With or Without Type 2 Diabetes/Prediabetes
por: Chukir, Tariq, et al.
Publicado: (2020)

SAT-095 The Impact of CPAP on Intensive Calorie Restriction Weight Loss
por: Mao, Yuanjie, et al.
Publicado: (2019)

SAT665 Effects Of Weight Cycling On Hepatic Protein Carbonylation And Lipid Peroxidation
por: Djalali-Gomez, Maya Aliyeh, et al.
Publicado: (2023)

The Effectiveness of Adding Pharmacotherapy to Dietary Counseling for Veterans in a Veterans Health Administration Move! Weight Management Program
por: Alvarez, Diego Alcaraz, et al.
Publicado: (2021)

SAT-LB019 Improvement of Visceral Fat and Body Composition Endpoints in Participants on Prescription Thyroid Replacement with a Doctor-Supervised Weight Loss Program
por: Dembrowski, Gerald, et al.
Publicado: (2019)

SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1
por: Srinath, Reshmi, et al.
Publicado: (2023)

SAT-120 Weight Regain after Bariatric Surgery Rectified by Dietary Intervention and Metformin
por: Torbay, Naji, et al.
Publicado: (2019)

OR01-2 Patient Characteristics Associated with Receipt of Prescription Weight Management Medications among Veterans in a Weight Management Program
por: Thomas, Dylan, et al.
Publicado: (2019)

SAT656 Weight Reduction After 6 Months Of Setmelanotide Treatment In Patients With Hypothalamic Obesity
por: Roth, Christian L, et al.
Publicado: (2023)

SAT-LB102 Obesity Is Associated With Reduced Expression of the Anorexigenic Neuropeptide Nucleobindin-2/Nesfatin-1 in the Human Nucleus of the Solitary Tract
por: Psilopanagioti, Aristea, et al.
Publicado: (2020)

SAT-595 Early Weight Gain Impact onto the Arcuate Leptin Receptor Expressing Neurons Activity During Development
por: Zampieri, Thais T, et al.
Publicado: (2020)

SAT-106 Plasma Interleukine-6 (IL-6) Concentration Is a Determinant of Free-Living Weight Change in Healthy Humans
por: Vinales, Karyne, et al.
Publicado: (2019)

SAT-119 Effect of Binge Eating Diagnosed Prior to Bariatric Surgery on Weight Loss up to 2 Years after Surgery
por: Friedman, Rogerio, et al.
Publicado: (2019)

SAT-108 Effects of Bariatric and Non-Bariatric Weight Loss on Migraine Headache in Obesity. A Systematic Review and Meta-Analysis
por: Di Vincenzo, Angelo, et al.
Publicado: (2019)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

SAT-LB022 Effects of Intermittent Versus Continuous Phentermine Therapy on Weight Reduction and Inflammatory Markers in Obese Non-diabetic Patients
por: Chai, Shu Teng, et al.
Publicado: (2019)

SAT649 Org43553, The First Low-molecular-weight Agonist Of The Human Luteinizing Hormone Receptor Induces Leanness And Energy Expenditure In Mice
por: Lizneva, Daria, et al.
Publicado: (2023)

SAT675 GLP-1RA Therapy And Intussusception: A Case Report Of Bowel Telescoping In Anobese Patient After Successful Weight Loss On Therapy
por: Alqaisi, Sura, et al.
Publicado: (2023)

SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study
por: Greenway, Frank, et al.
Publicado: (2019)

SAT-097 Weight Loss With Liraglutide 3.0 Mg Versus Placebo For Individuals Who Adhere To The Trial Drug: A Secondary Analysis From SCALE IBT
por: Shaw Tronieri, Jena, et al.
Publicado: (2019)

SAT-105 Weight Loss As Determined By Adherence To Reduced Caloric Diet, Increased Physical Activity, Liraglutide 3.0 Mg and Placebo: A Sub-analysis Of The SCALE IBT Trial
por: Shaw Tronieri, Jena, et al.
Publicado: (2019)

SUN-102 Spexin Differentially Regulates Adipogenesis in Brown and White Adipose Tissue Depots
por: Sherman, Shermel, et al.
Publicado: (2019)

SUN-LB102 Development of a Conceptual Model to Present the Impacts of Obesity on Physical Functioning
por: Poon, Jiat Ling, et al.
Publicado: (2020)

Is Insulin Resistance at Baseline a Predictor of Weight Loss After Bariatric Surgery?
por: Borges-Canha, Marta, et al.
Publicado: (2021)

RF24 | PSUN95 Defining Predictors of Weight Loss Response to Lorcaserin
por: Gugger, Aristea Sideri, et al.
Publicado: (2022)

FRI074 Rise In Fasting Ghrelin Level In Response To Weight Loss Predicts Future Weight Regain In The POUNDS LOST Trial
por: Tong, Jenny, et al.
Publicado: (2023)

SAT-585 Autoregulation of Adipose Tissue Development
por: Feldman, Brian, et al.
Publicado: (2020)

SAT680 Mounjaro: A Side Effect
por: Rao, Kamini, et al.
Publicado: (2023)

SAT678 Metabolic Disorders In Thalidomide Embryopathy
por: Tanabe, Akiyo
Publicado: (2023)

ODP006 Multidisciplinary Weight Management Improves Body Weight And Body Mass Composition In Breast Cancer Women Undergoing Adjuvant Chemotherapy
por: Nguyen, Vivien, et al.
Publicado: (2022)

SAT648 The Role Of Olfactory Marker Protein On Adipogenesis
por: Bao, Yaru, et al.
Publicado: (2023)

Clinically-Relevant Weight Loss is Achieved Independently of Early Weight Loss Response to Once-Weekly Subcutaneous Semaglutide 2.4 MG (STEP 4)
por: Mosenzon, Ofri, et al.
Publicado: (2021)

Engagement in a Multi-Feature Digital Health Lifestyle Change Program as a Predictor of Weight Loss
por: Dzubur, Eldin, et al.
Publicado: (2021)

SAT-115 Body Image Dissatisfaction and Distortion in Bariatric Patients
por: Naliato, Erika, et al.
Publicado: (2019)

SAT670 Is Myostatin A Biomarker Of Skeletal Muscle Mass?
por: Orioli, Laura, et al.
Publicado: (2023)

SAT674 Lipodystrophy: A Hidden Culprit In Uncontrolled Diabetes
por: Sayed, Farah El, et al.
Publicado: (2023)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dndbtmjr7rl5iqkir4cfu4sodj